Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial

Autor: Heerspink, Hiddo J.L., Birkenfeld, Andreas L., Cherney, David Z.I., Colhoun, Helen M., Ji, Linong, Mathieu, Chantal, Groop, Per-Henrik, Pratley, Richard E., Rosas, Sylvia E., Rossing, Peter, Skyler, Jay S., Tuttle, Katherine R., Lawatscheck, Robert, Scott, Charlie, Edfors, Robert, Scheerer, Markus F., Kolkhof, Peter, McGill, Janet B.
Zdroj: In Diabetes Research and Clinical Practice October 2023 204
Databáze: ScienceDirect
Externí odkaz: